Loading...
XJPX
2269
Market cap6.34bUSD
Apr 11, Last price  
3,357.00JPY
1D
-2.13%
1Q
6.81%
Jan 2017
-63.35%
IPO
103.45%
Name

Meiji Holdings Co Ltd

Chart & Performance

D1W1MN
XJPX:2269 chart
No data to show
P/E
17.95
P/S
0.82
EPS
187.07
Div Yield, %
2.90%
Shrs. gr., 5y
-13.62%
Rev. gr., 5y
-2.50%
Revenues
1.11t
+4.08%
710,908,000,000702,750,000,000706,988,000,000711,394,000,0001,106,655,000,0001,114,095,000,0001,109,275,000,0001,126,520,000,0001,148,076,000,0001,161,152,000,0001,223,746,000,0001,242,480,000,0001,240,860,000,0001,254,380,000,0001,252,706,000,0001,191,765,000,0001,013,092,000,0001,062,157,000,0001,105,494,000,000
Net income
50.68b
-27.01%
10,055,000,00013,708,000,0009,226,000,0005,933,000,00013,088,000,0009,552,000,0006,805,000,00016,646,000,00019,060,000,00030,891,000,00062,580,000,00060,786,000,00061,278,000,00061,868,000,00067,313,000,00065,655,000,00087,497,000,00069,424,000,00050,675,000,000
CFO
107.98b
+27.02%
31,256,000,00037,123,000,00018,542,000,00016,991,000,00047,707,000,00057,995,000,00030,597,000,00050,622,000,00063,847,000,00086,487,000,000105,155,000,00081,888,000,000108,775,000,000112,100,000,000114,103,000,000123,683,000,000127,526,000,00085,013,000,000107,983,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
May 08, 2025

Profile

Meiji Holdings Co., Ltd., through its subsidiaries, manufactures and sells dairy products, confectioneries, nutritional products, and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceutical. It provides yogurt, cheese, drinking milk, beverages, butter and margarine, cream, ice cream, ready meals, chocolates, gummy products, chewing gums, sports nutrition products, infant formula, liquid diet, beauty supplements, OTC medicines, feed stuffs, corn sweeteners, and sugar, as well as transportation and distribution services. The company also offers drugs for infectious diseases and central nervous system disorders, as well as generic drugs; agricultural and livestock chemicals; human and animal vaccines, and blood plasma products; and veterinary drugs for livestock and fisheries comprising antimicrobial injection, disinfectants, oral administration, insecticides, anthelmintic, antipyretic, analgesic, anti-inflammatory, hemostatic, and breeding agents. In addition, it provides insecticides, metabolites, feed additives, and mixed feed; and companion animals, including anesthetics and painkillers, anti-parasitic and gastrointestinal drugs, anti-bacterial agents, antiplasmin agents, vitamin E preparations, and dietary supplements. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.
URL
https://www.meiji.com/
IPO date
Apr 01, 2009
Employees
17,290
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
1,105,494,000
4.08%
1,062,157,000
4.84%
Cost of revenue
1,030,710,000
986,722,000
Unusual Expense (Income)
NOPBT
74,784,000
75,435,000
NOPBT Margin
6.76%
7.10%
Operating Taxes
33,792,000
23,912,000
Tax Rate
45.19%
31.70%
NOPAT
40,992,000
51,523,000
Net income
50,675,000
-27.01%
69,424,000
-20.66%
Dividends
(26,444,000)
(24,606,000)
Dividend yield
2.80%
2.78%
Proceeds from repurchase of equity
1,057,000
(9,502,000)
BB yield
-0.11%
1.07%
Debt
Debt current
22,330,000
(43,664,000)
Long-term debt
27,593,000
53,461,000
Deferred revenue
3,878,000
56,331,000
Other long-term liabilities
58,922,000
7,326,000
Net debt
(181,619,000)
(188,104,000)
Cash flow
Cash from operating activities
107,983,000
85,013,000
CAPEX
(50,023,000)
(72,170,000)
Cash from investing activities
(24,604,000)
(36,788,000)
Cash from financing activities
(43,772,000)
(54,734,000)
FCF
42,279,000
(59,698,000)
Balance
Cash
106,858,000
63,519,000
Long term investments
124,684,000
134,382,000
Excess cash
176,267,300
144,793,150
Stockholders' equity
697,419,000
718,202,000
Invested Capital
724,251,700
734,542,850
ROIC
5.62%
7.72%
ROCE
8.26%
8.53%
EV
Common stock shares outstanding
278,984
280,633
Price
3,386.00
7.32%
3,155.00
-52.27%
Market cap
944,639,824
6.69%
885,397,115
-76.76%
EV
804,281,824
736,687,115
EBITDA
130,112,000
129,025,000
EV/EBITDA
6.18
5.71
Interest
367,000
462,000
Interest/NOPBT
0.49%
0.61%